Last $14.55 USD
Change Today +0.22 / 1.54%
Volume 296.2K
THRX On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rick E. Winningham

Former Chairman of the Board, Member of Stock Option Committee and Member of Science & Technology Advisory Committee, Theravance Inc.
AgeTotal Calculated CompensationThis person is connected to 72 board members in 5 different organizations across 6 different industries.

See Board Relationships
54--
As of Fiscal Year 2013

Background*

Mr. Rick E. Winningham has been Chairman and Chief Executive Officer at Theravance Biopharma, Inc. since its spin-off from Theravance, Inc. in June 2014. Mr. Winningham served as the Chief Executive Officer of Theravance Inc. since October 2001 until August 15, 2014. Mr. Winningham served as President of Theravance Inc. since October 2001. From 1997 to 2001, Mr. Winningham served as the President, Bristol-Myers Squibb Oncology /Immunology /Oncology Therapeutics Network ...

Read Full Background

Corporate Headquarters*

951 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-238-9600
Fax: --

Board Members Memberships*

Director
Chairman, Chief Executive Officer and Member of Science & Technology Committee
2001-2014
Former Chairman of the Board, Member of Stock Option Committee and Member of Science & Technology Advisory Committee
2011-Present
Director
2012-Present
Lead Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

MBA
Texas Christian University
BS
Southern Illinois University, Carbondale Campus

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THRX:US $14.55 USD +0.22

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Bonney B.A.Chief Executive Officer and Director
Cubist Pharmaceuticals Inc.
$750.0K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAVANCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.